Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Cambrex, a CMO of small-molecule active pharmaceutical ingredients and drug products, has been acquired by an affiliate of Permira Funds, private-equity firm, for approximately $2.4 billion, including Cambrex’s net debt. The companies had announced...

WuXi Vaccines, a subsidiary WuXi Biologics focused on contract development and manufacturing services for vaccines, is investing $240 million to build a new vaccine-manufacturing facility in Ireland. This investment follows a 20-year manufacturing...

Lonza has announced that Marc Funk, Chief Executive Officer (CEO), will leave the company for personal reasons. The Board of Directors also announced that Albert Baehny, Chairman, will take on the additional responsibility of CEO on an interim...

Recipharm, a CDMO of active pharmaceutical ingredients (APIs) and drug products, has agreed to acquire Consort Medical, the parent company of Aesica, a CDMO of APIs and drug products, and Bespak, a CDMO of drug devices, for £505 million ($652...

The latest news from CDMOs, CMOs, and suppliers featuring news from Colorcon, PCI Pharma Services, Almac and AMRI. Formulation Development/Drug Product Manufacturing Colorcon Launches $50-Million Venture Capital Fund Colorcon, an excipients...